Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  MEDNAX Inc    MD

Delayed Quote. Delayed  - 05/04 10:02:01 pm
69.09 USD   -1.41%
05/04 MEDNAX : to Present at the Bank of America Merrill Lynch 2016 Health..
05/02 MEDNAX : MedData to Acquire Leading Patient Engagement Software Deve..
04/28 MEDNAX : meets 1Q profit forecasts
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Sales2 1542 439-3 1353 4243 816
Operating income (EBITDA)492559654685754818
Operating profit (EBIT)452513632604620761
Pre-Tax Profit (EBT)448-----
Net income281317-350388439
P/E ratio19,220,820,019,916,915,3
EPS ( $ )2,783,183,583,514,154,60
Dividend per Share ( $ )------
Yield------
Reference price ( $ )53.3866.1171.6670.0870.0870.08
Announcement Date01/30/2014
11:00am
01/29/2015
11:00am
----
Finances - Leverage
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Debt-515-1 129962-
Finance10,4-----
Operating income (EBITDA)492559654685754818
Leverage
(Debt/EBITDA)
-0,92x-1,65x1,28x-
Capital Expenditure15,618,127,136,530,835,0
Book Value Per Share (BVPS)23,2 $22,6 $25,9 $29,2 $32,3 $34,8 $
Cash Flow per Share4,02 $4,23 $3,92 $5,32 $5,66 $5,80 $
Announcement Date01/30/2014
11:00am
01/29/2015
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 6 519 M$ -
Entreprise Value (EV) 7 648 M$ 7 481 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 19,9x 16,9x
Capitalization / Revenue 2,08x 1,90x
EV / Revenue 2,44x 2,18x
EV / EBITDA 11,2x 9,92x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 2,40x 2,17x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 19,3% 18,1%
operating Leverage (Delta EBIT / Delta Sales) - 0,27x
Net Margin (Net Profit / Revenue) 11,2% 11,3%
ROA (Net Profit / Asset) 7,40% 7,60%
ROE (Net Profit / Equities) 14,0% 13,8%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   1,16% 0,90%
Cash Flow / Sales 15,8% 15,4%
Capital Intensity (Assets / Sales) 1,51x 1,49x
Financial Leverage (Net Debt / EBITDA) 1,65x 1,28x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend